BusinessNovelion Therapeutics Announces Presentation of Metreleptin Data at American Diabetes AssociationBy Nasdaq OMXJun 12, 2017, 12:30 PM UTC
BusinessNovelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical EndocrinologyBy Nasdaq OMXMay 5, 2017, 1:01 PM UTC
BusinessNovelion Therapeutics Announces Presentation of Metreleptin Data at American Association of Clinical EndocrinologyBy Nasdaq OMXMay 5, 2017, 1:01 PM UTC
BusinessNovelion Therapeutics’ Subsidiary Announces New Data to be Presented at the Annual Meeting of the Endocrine SocietyBy Nasdaq OMXMar 30, 2017, 8:15 PM UTC